The pivotal SURPASS clinical trial program for type 2 diabetes enrolled over 10,000 participants across multiple international sites, demonstrating tirzepatide's efficacy across a range of baseline characteristics and disease severities
If vial-and-syringe technique feels overwhelming at the start, beginning with a pen and transitioning to vials later is a completely valid approach
Contact your GP or call NHS 111 for symptoms such as persistent nausea, vomiting, palpitations, or injection site reactions
The buying problem is that DSIP has thin evidence relative to its market presence
The 1mg capsules are recommended to be taken once daily, while the 250g and 500g capsules are recommended to be taken once to twice daily
And the clinical data behind it including cardiovascular outcomes, weight loss percentages, and long-term safety comes from trials involving tens of thousands of patients